Antibody–Drug Conjugates (ADCs)
AI-designed programmable linkers that improve payload stability, controlled release, and tumor selectivity — enabling next-generation ADC therapeutics with improved therapeutic index.
Peptide–Drug Conjugates (PDCs)
Programmable peptide scaffolds engineered for tissue-targeted delivery with tunable pharmacokinetics and reduced off-target toxicity.
Nucleic Acid Conjugation
Precision conjugation of siRNA, ASO, and mRNA with targeting ligands and delivery carriers — expanding the reach and efficacy of nucleic acid therapeutics.
Protein Degraders
Programmable bifunctional molecules — PROTACs and molecular glues — engineered with AI-optimized linkers for targeted intracellular protein degradation.